If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 161 - 170 of 309
A Global Multicenter, Double-Blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination With Azacitidine (AZA) in Patients With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4)
Objective
A Phase 3 Study of Lisaftoclax in Patients with Newly Diagnosed High-Risk Myelodysplastic Syndrome
Protocol No
ASCENTAGE-APG2575MG301-GLORA-4
Categories
Reducing Neoplasia Recurrence After Endoscopic Resection of Large Colorectal Polyps
Objective
Reducing Neoplasia Recurrence After Endoscopic Resection of Large Colorectal Polyps
Protocol No
CHUM-ABLATION
Categories
Complete Closure After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps: a Randomized Controlled Trial
Objective
Complete Closure After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps (Closure-RCT)
Protocol No
GI-CHUM-CLOSURE-RCT
Categories
Partial Enteral Nutrition as Therapeutic Augmentation of Advanced Pharmacological Therapy in Patients With Active Crohn's Disease
Objective
PEN as Therapeutic Augmentation of Advanced Pharmacological Therapy in Patients With Active CD
Protocol No
GI-PENN-PANDORA
Categories
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
Objective
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
Protocol No
IIT-HALL-MRI-ENHANCE
Categories
Radiotherapy With Concurrent Cetuximab vs. Carboplatin and Paclitaxel in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin: A Pragmatic Phase III Randomized Trial
Objective
A Phase III Head And Neck Study Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy
Protocol No
NRG-HN016
Categories
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
Objective
Study of bispecific antibody therapy for post-BCMA therapy relapse
Protocol No
IIT-DHAKAL-RECLAIM
Categories
Multicenter Phase II Study of Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
Objective
Multicenter Phase II Study of Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
Protocol No
IIT-SHAH-ELDERLY-DLBCL
Categories
A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Primary Progressive Multiple Sclerosis
Objective
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Protocol No
NEURO-ZENAS-PRIMROSE
A Single-Arm, Open-Label, Phase II Study Evaluating Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors; (POSTPONE)
Objective
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
Protocol No
IIT-KILARI-POSTPONE
Categories